Malignant Tumors and Cancer Pathophysiology
19 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What does carcinoma in situ (CIS) refer to?

Carcinoma in situ refers to an early stage of cancer that is localized to the epithelium.

What is a malignant tumor?

A malignant tumor is a type of tumor that is cancerous and can invade other tissues.

Which of the following are types of genetic lesions associated with cancer?

  • Point mutation
  • Chromosome translocation
  • Gene amplification
  • All of the above (correct)
  • What do oncogenes do?

    <p>Oncogenes stimulate uncontrolled cellular proliferation.</p> Signup and view all the answers

    What is the significance of tumor-suppressor genes?

    <p>Tumor-suppressor genes prevent uncontrolled cell growth.</p> Signup and view all the answers

    What is a consequence of loss of heterozygosity (LOH) in cancer?

    <p>All of the above</p> Signup and view all the answers

    Chronic inflammation is associated with cancer development.

    <p>True</p> Signup and view all the answers

    What is the role of tumor-associated macrophages (TAMs) in cancer?

    <p>TAMs promote tumor survival and secrete growth factors that enhance tumor growth.</p> Signup and view all the answers

    What are some side effects of chemotherapy?

    <p>All of the above</p> Signup and view all the answers

    What is the foremost hallmark of cancer?

    <p>Uncontrolled cellular proliferation</p> Signup and view all the answers

    What is carcinoma in situ (CIS)?

    <p>An early stage cancer localized to the epithelium</p> Signup and view all the answers

    Genetic lesions contribute to cancer development.

    <p>True</p> Signup and view all the answers

    The increased activity of the telomerase enzyme maintains __________ length.

    <p>telomere</p> Signup and view all the answers

    Which types of mutations are classified as driver mutations?

    <p>Mutations that drive cancer progression</p> Signup and view all the answers

    What is the role of tumor-suppressor genes?

    <p>To prevent uncontrolled cell growth</p> Signup and view all the answers

    What does chronic inflammation contribute to?

    <p>Cancer development</p> Signup and view all the answers

    Tumor-associated macrophages (TAMs) support tumor growth.

    <p>True</p> Signup and view all the answers

    What are the side effects of chemotherapy?

    <p>All of the above</p> Signup and view all the answers

    Human papillomavirus is associated with __________ infections.

    <p>viral</p> Signup and view all the answers

    Study Notes

    Malignant Tumors

    • Characterized by uncontrolled cell division and the ability to invade other tissues.
    • Tumors can be classified as benign (non-cancerous) or malignant (cancerous).
    • Carcinoma in situ (CIS) is an early stage localized cancer confined to the epithelium.

    Cancer Development and Pathophysiology

    • Pathophysiology includes mechanisms of cancer cell survival, advanced malignancies, and heritable cancers.
    • Overexpression of telomerase enzyme maintains telomere length, contributing to cellular immortality.

    Genetic Lesions

    • Types include point mutations, chromosome translocations, gene amplifications.
    • Driver mutations are responsible for cancer progression, while passenger mutations are non-contributing.

    Oncogenes and Proto-oncogenes

    • Hallmark of cancer is uncontrolled cellular proliferation.
    • Proto-oncogenes regulate normal cell growth; mutations can convert them into oncogenes, leading to sustained proliferation.
    • Example: RAS oncogene continuously stimulates cell growth due to a mutation that prevents its deactivation.

    Tumor-Suppressor Genes

    • Functions include controlling cell cycle and DNA repair processes.
    • Heritable mutations in tumor-suppressor genes can lead to familial cancers, such as:
      • Retinoblastoma (RB gene)
      • Neurofibromatosis (NF1 gene)
      • Breast cancer (BRCA1 gene)
      • Polyposis/colon cancer (APC gene)

    Consequences of Loss of Heterozygosity (LOH) in Cancer

    • Unmasking recessive mutations leads to tumor suppressor gene inactivation and uncontrolled cell growth.
    • Contributes to increased cancer risk by affecting DNA repair and cell cycle control genes.
    • Heterogeneity within tumors can impact treatment response and outcomes.
    • Microsatellite Instability (MSI) refers to errors in repetitive DNA sequences that contribute to cancer.

    Telomeres and Telomerase in Cancer

    • Telomeres protect chromosome ends; telomerase maintains their length.
    • Dysregulation can lead to tumorigenesis.

    Tumor Manipulation of Immune Responses

    • Tumors can alter inflammatory and immune responses to promote survival (wound healing phenotype).
    • Tumor-associated macrophages (TAMs) support tumor growth through cytokine release and suppression of cytotoxic immune responses.
    • TAMs display an anti-inflammatory phenotype, promoting neovascularization and cellular proliferation.

    Epigenetic Processes

    • Involves mechanisms like loss of function mutations affecting gene expression, contributing to cancer development.

    Inflammation, Immunity, and Cancer

    • Chronic inflammation is a significant factor in cancer pathophysiology.

    Viral Infections and Cancer

    • Human papillomavirus (HPV) is linked to various cancers through immune evasion mechanisms.
    • Helicobacter pylori disrupts gastric pH and causes inflammation, a precursor to certain cancers.

    Tumor Staging

    • Involves classification based on tumor size, node involvement, and metastasis, helping to guide treatment.

    Chemotherapy Side Effects

    • Common side effects include:
      • Gastrointestinal: Nausea and vomiting
      • Hematologic: Myelosuppression, anemia
      • Dermatologic: Hair loss (alopecia), skin changes
      • Reproductive: Infertility and related issues

    Cancer Prevention

    • Emphasizes healthy behaviors, particularly physical activity, to reduce cancer risk.

    Malignant Tumors

    • Characterized by uncontrolled cell division and the ability to invade other tissues.
    • Tumors can be classified as benign (non-cancerous) or malignant (cancerous).
    • Carcinoma in situ (CIS) is an early stage localized cancer confined to the epithelium.

    Cancer Development and Pathophysiology

    • Pathophysiology includes mechanisms of cancer cell survival, advanced malignancies, and heritable cancers.
    • Overexpression of telomerase enzyme maintains telomere length, contributing to cellular immortality.

    Genetic Lesions

    • Types include point mutations, chromosome translocations, gene amplifications.
    • Driver mutations are responsible for cancer progression, while passenger mutations are non-contributing.

    Oncogenes and Proto-oncogenes

    • Hallmark of cancer is uncontrolled cellular proliferation.
    • Proto-oncogenes regulate normal cell growth; mutations can convert them into oncogenes, leading to sustained proliferation.
    • Example: RAS oncogene continuously stimulates cell growth due to a mutation that prevents its deactivation.

    Tumor-Suppressor Genes

    • Functions include controlling cell cycle and DNA repair processes.
    • Heritable mutations in tumor-suppressor genes can lead to familial cancers, such as:
      • Retinoblastoma (RB gene)
      • Neurofibromatosis (NF1 gene)
      • Breast cancer (BRCA1 gene)
      • Polyposis/colon cancer (APC gene)

    Consequences of Loss of Heterozygosity (LOH) in Cancer

    • Unmasking recessive mutations leads to tumor suppressor gene inactivation and uncontrolled cell growth.
    • Contributes to increased cancer risk by affecting DNA repair and cell cycle control genes.
    • Heterogeneity within tumors can impact treatment response and outcomes.
    • Microsatellite Instability (MSI) refers to errors in repetitive DNA sequences that contribute to cancer.

    Telomeres and Telomerase in Cancer

    • Telomeres protect chromosome ends; telomerase maintains their length.
    • Dysregulation can lead to tumorigenesis.

    Tumor Manipulation of Immune Responses

    • Tumors can alter inflammatory and immune responses to promote survival (wound healing phenotype).
    • Tumor-associated macrophages (TAMs) support tumor growth through cytokine release and suppression of cytotoxic immune responses.
    • TAMs display an anti-inflammatory phenotype, promoting neovascularization and cellular proliferation.

    Epigenetic Processes

    • Involves mechanisms like loss of function mutations affecting gene expression, contributing to cancer development.

    Inflammation, Immunity, and Cancer

    • Chronic inflammation is a significant factor in cancer pathophysiology.

    Viral Infections and Cancer

    • Human papillomavirus (HPV) is linked to various cancers through immune evasion mechanisms.
    • Helicobacter pylori disrupts gastric pH and causes inflammation, a precursor to certain cancers.

    Tumor Staging

    • Involves classification based on tumor size, node involvement, and metastasis, helping to guide treatment.

    Chemotherapy Side Effects

    • Common side effects include:
      • Gastrointestinal: Nausea and vomiting
      • Hematologic: Myelosuppression, anemia
      • Dermatologic: Hair loss (alopecia), skin changes
      • Reproductive: Infertility and related issues

    Cancer Prevention

    • Emphasizes healthy behaviors, particularly physical activity, to reduce cancer risk.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Cancer Study Guide PDF

    Description

    Explore the complexities of malignant tumors and their development in this quiz. Test your knowledge on cancer types, genetic lesions, and the role of oncogenes. Understand the mechanisms behind cancer proliferation and survival.

    More Like This

    Use Quizgecko on...
    Browser
    Browser